• Search
  • Login
  • Register
Menu
  • Last issue
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
  • Reimbursement News
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here

Category

All
  • Alle
  • General
  • Healthy Living
  • Pharma News
  • Health of Tomorrow
  • Viewpoints
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
  • Podcasts
  • Therapy
  • Editor's pick
  • Covid-19
  • Society Announcement
  • Reimbursement News

Specialty

All
  • Alle
  • YESCARTA
  • BEKEMV
  • NPLATE
Clinical trials

Efficacy and safety of emicizumab demonstrated in people with mild or moderate haemophilia A

subscribe Latest issue All issues Newsletters
Index latest issue
  • INTRODUCTION
  • Restoring the delicate coagulation balance in haemophilia
  • Non-myeloablative haploidentical haematopoietic stem cell transplantation for adult patients with sickle cell disease: Current status and future perspectives
  • Unveiling cytokine profiles: HLH induced by the combination of cemiplimab and venetoclax
  • Clinical importance of screening for the neglected acquired von Willebrand syndrome in patients with myeloproliferative neoplasms: A case series
  • Journal scan
  • New haematology reimbursements in Belgium
Clinical trials

Adding daratumumab to bortezomib-dexamethasone improves survival in myeloma patients

Clinical practice

Anaemia as a mediator of adverse pregnancy outcomes in sickle cell disease

Clinical trials

G-CSF, decitabine and busulfan-cyclophosphamide conditioning for MDS and secondary AML

Pharma News

FDA approves efanesoctocog alfa for the treatment of haemophilia A

Medical Research

Mitochondrial fusion as a new therapeutic target in acute myeloid leukaemia

Science

Amsterdam scientists investigate why immunotherapy fails in Chronic Lymphocytic Leukaemia

Previous 10 11 12 13 14 15 16 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2025